Donate Now
  • Research Completed
Increasing and improving physical activity for patients with inflammatory arthritis
Rheumatoid-Arthritis-6.0-1
Scientific Study Title:
Effectiveness of Online Physical Activity Monitoring in Inflammatory Arthritis (OPAM-IA): A New Model of Care
Start Date:
  • January 2017
End Date:
  • Recruitment Completed in 2019
Research Category
Tags
iAPIwJt8fXo1AW_OpaKC-A44VD9vdC8pB_T175A3qyo
Linda Li
Senior Scientist, Implementation Science, BSc(PT), MSc, PhD, FCAHS
J. Antonio Avina-Zubieta-Website Headshot-400x400
J. Antonio Aviña-Zubieta
Senior Scientist, Rheumatology, MD, MSc, PhD, FRCP
7fVkTRTuX6B8N-CGL1vUPIxh2G5yG7LcGTDHIVUdfa4
Catherine Backman
Senior Scientist Emeritus, Rehabilitation, PhD, FCAOT
rm8kf5Uo_xM8GrwetvZNvXgqfYHObDbxojo80Qt3JUo
Jenny Leese
MA, PhD, Post-Doctoral Fellow
HXXq7aA4SujuaGgxS9en5va-87Xwgz2FT5lfUcngW_o
John Esdaile
Scientific Director Emeritus, MD, MPH, FRCPC, FCAHS, MACR
ltSaHfNwsd-2XrV0MY9ZRj8NjYgheq6u5kPIBFn8V_I
Kamran Shojania
Clinical Trialist, Rheumatology, MD, FRCPC
Shahin Jamal-Website Headshot-400x400
Shahin Jamal
Clinician Investigator, MD, FRCPC, MSc

Why do this research?

Reason For Research

Physical activity is important in managing arthritis.

Reasons for inactivity include motivation, exercise doubts and limited counselling.

To address the problem of inactivity, we will test a new program at improving physical activity among rheumatoid (RA) and systemic lupus erythematosus (SLE) patients.

Methodology

Execution of Research

OPAM-IA is a program that uses Fitbit Flex (wireless physical activity tracker) paired with FitViz (new application), and physical activity counselling to help people with RA and SLE be more physically active safely and at their own pace. Physical activity information will be collected by the Fitbit Flex and viewed through the FitViz by a physiotherapist to guide participant’s progress.

The OPAM-IA program consists of:

  1. A one-time group education session in the Greater Vancouver Area
  2. Using Fitbit Flex and FitViz app
  3. Online/telephone physical activity counselling.

Who is involved?

Involvement

Our team consists of 7 co-investigators, 6 research staff and 12 collaborators. Sixty people with RA and sixty people with SLE will be recruited. Eligibility criteria consists of:

  1. RA or SLE diagnosis.
  2. No previous experience in using any physical activity wearables.

Participants will be randomly assigned to one of the two groups to either receive the intervention immediately or wait 2 months before getting the intervention. Participants in the Immediate Group will be asked to attend a group education session, use a Fitbit Flex with the FitViz app, and receive counselling by a registered physiotherapist. Participants in the Delayed Group will wait 2 months to start the same intervention. Throughout the study, assessments will be done at the beginning, and at the end of months 2, 4, and 6. These assessments include an online questionnaire and wearing another research based accelerometer for 7 days.

For more information, please view the OPAM-IA recruitment notice. If you are Interested in participating, you can click here to access our short screening questionnaire and contact the study coordinator.

Contact: Juliane Chien, Research Assistant
Phone: 604.207.4032 | National Toll Free: 1.844.707.4032
Email: jchien@arthritisresearch.ca

Related Publications

Li LC, Feehan LM, Shaw C, Xie H, Sayre EC, Aviña-Zubeita A, Grewal N, Townsend AF, Gromala D, Noonan G, Backman CL. A technology-enabled counselling program versus a delayed treatment control to support physical activity participation in people with inflammatory arthritis: study protocol for the OPAM-IA randomized controlled trial. BMC Rheumatology. (DOI: 10.1186/s41927-017-0005-4) 1:6, 2017. To access publication, click here.

Li LC, Feehan LM, Xie H, Lu N, Shaw C, Gromala D, JA Avina-Zubieta, Koehn C, Hoens AM, English K, Tam J, Therrien S, Townsend AF, Noonan G, Backman CL. Efficacy of a Physical Activity Counselling Program with Use of Wearable Tracker in People with Inflammatory Arthritis: A Randomized Controlled Trial. Arthritis Care & Research. (DOI: 10.1002/acr.24199; E-pub ahead of print) 2020. To access publication, click here.

Share this on social media

External Partners & Contacts

Greg Noonan, Mary Pack Arthritis Program

Paul Adam, Mary Pack Arthritis Program

Dr. Leigh Callahan, Thurston Arthritis Research Center

Pam Montie, Arthritis Patient Advisory Board

Cherly Koehn, Arthritis Consumer Experts

John Esdaile, MD, MPH, FRCPC, FCAHS, MACR, Scientific Director Emeritus, Arthritis Research Canada (University of British Columbia)

Kamran Shojania, MD, FRCPC, Clinical Trialist, Rheumatology, Arthritis Research Canada (University of British Columbia)

Dr. David Collins, (University of British Columbia)

Dr. Jason Kur, Pacific Arthritis Centre

Dr. Jennifer Reynolds, Vancouver General Hospital

Dr. Ken Blocka, (University of British Columbia)

Shahin Jamal, MD, FRCPC, MSc, Clinician Investigator, Arthritis Research Canada, (University of British Columbia)

Related Research

Rheumatoid-Arthritis-2.0-1

Améliorer la qualité des soins pour la polyarthrite rhumatoïde

Read More
Connecting Voices-PLS-715 x 405

Connecting Voices for Equitable Rheumatoid Arthritis Care Access

Read More
New Model of At-Home Follow-Up Care_PLS

A New Model of At-Home Follow-Up Care for Rheumatoid Arthritis

Read More
Kinesiologists-and-Exercise-Physiologists-PLS-Feature-Image-425x296-1

Preparing kinesiologists and exercise physiologists: what does this mean for arthritis care?

Read More
Research-Stream-AI-Study_425x296

Using Artificial Intelligence to Streamline Research on Rheumatoid Arthritis Treatments

Read More
2026-Studies-to-Watch-Decision-Aid

Evaluating a Decision Aid for Tapering Biologic Medications in Rheumatoid Arthritis

Read More